It showed that associations between SFRP4 and tumor phenotype (p ≤ 0.05 each, Table 3) and PSA recurrence (p < 0.0001, Fig. 2b) were largely driven by the subgroup of cancers lacking ERG fusion. Here, SFRP4 is linked to cancer.